U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07721350) titled 'Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE(R) Infusion System' on July 07.
Brief Summary: This study is evaluating a new method for administering daratumumab, a treatment commonly used in the management of multiple myeloma and amyloidosis. For several years, this treatment has been administered by subcutaneous injection in just a few minutes, significantly reducing the amount of time patients spend in hospital. Currently, this injection is performed manually by nurses. Although effective, this method may be demanding in daily practice due to the repetitive nature of the procedure and the ...